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Background: Transplantation brings sustainably improved quality of life to patients with end-stage organ failure.
Persisting shortfall in available organs prompted French authorities and practitioners to focus on organ retrieval in
patients withdrawn from life-sustaining treatment and awaiting cardiac arrest (Maastricht classification category III).
The purpose of this study was to assess the theoretical eligibility of non-heart-beating donors dying in the intensive
care unit (ICU) after a decision to withhold or withdraw life-sustaining treatment (WoWt).
Methods: We collected the clinical and biological characteristics of all consecutive patients admitted to our ICU
and qualified for a WoWt procedure under the terms of the French Leonetti law governing end-of-life care during a
12-month period. The theoretical organ donor eligibility (for kidney, liver, or lung retrieval) of deceased patients was
determined a posteriori 1) according to routine medical criteria for graft selection and 2) according to the WoWt
measures implemented and their impact on organ viability.
Results: A total of 596 patients (mean age: 67 ± 16 yr; gender ratio M/F: 1.6; mean SAPS (Simplified Acute
Physiology Score) II: 54 ± 24) was admitted to the ICU, of which 84 patients (mean age: 71 ± 14 yr, 14% of
admissions, gender ratio M/F: 3.2) underwent WoWt measures. Eight patients left the unit alive. Forty-four patients
presented a contraindication ruling out organ retrieval either preexisting admission (n = 20) or emerged during
hospitalization (n = 24). Thirty-two patients would have been eligible as kidney (n = 23), liver (n = 22), or lung donors
(n = 2). Cardiopulmonary support was withdrawn in only five of these patients, and three died within 120 minutes
after withdrawal (the maximum delay compatible with organ viability for donor grafts).
Conclusions: In this pilot study, a significant number of patients deceased under WoWt conditions theoretically
would have been eligible for organ retrieval. However, the WoWt measures implemented in our unit seems
incompatible with donor organ viability. A French multicenter survey of end-of-life practices in ICU may help to
identify potential appropriate organ donors and to interpret nation-specific considerations of the related
professional, legal, and ethical frameworks.
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Qualified as a worldwide shortage, the widening gap
between organ demand (i.e., patients in terminal organ
failure) and donor graft supply is forcing a rethink of the
practical and ethical issues tied to organ transplantation.
French policy on organ retrieval essentially hinges on
brain dead donors (termed “heart-beating donors”). Dur-
ing the past decade, organ donation following traumatic
brain death has become scarcer. Efforts to maintain a
pool of available grafts revolved around extending the
donor selection criteria to include elderly and/or chro-
nically ill patients (such as diabetics or arterial hy-
pertension sufferers) whose death mostly results from
cerebrovascular accidents. This policy seems to have
reached its limits and cannot now keep pace with de-
mand. Some countries have developed all or part of their
transplantation policy on donation after circulatory ar-
rest [1-4]. In 1995, Dutch transplant surgeons separated
out four categories of circulatory arrest death (CAD)
into what is known as the Maastricht classification
[5]: unforeseeable irreversible circulatory arrest without
(category I) or with (category II) immediate cardiopul-
monary resuscitation attempted by trained providers
(uncontrolled CAD), foreseeable circulatory arrest oc-
curring after a decision to withhold or withdraw life-
sustaining treatment (WoWt) (category III, controlledFigure 1 Organ harvesting under Maastricht I, II, and III settings. The
arrest death (CAD): unforeseeable irreversible circulatory arrest without (cat
attempted by trained providers (uncontrolled CAD, right side of the panel),
withdraw life-sustaining treatment (WoWt) (category III or controlled CAD, l
(category IV, not displayed on the panel).CAD), circulatory arrest occurring after brain death
(category IV). Donations after unforeseeable irreversible
circulatory arrest (uncontrolled CAD, right-side panel of
Figure 1) are authorized in France since 2005 [6]. As the
procedure is restricted to a small number of suitably
equipped centers, relatively few organs have been re-
trieved under this system. Organ harvesting in patients
deceased under WoWt circumstances (controlled CAD,
left panel of Figure 1) is still not legally framed in
France. The National Academy of Medicine, the Na-
tional Ethics Advisory Authority (CCNE), and Anesthe-
sia and Critical Care councils had previously voiced
concerns over such a procedure arguing that it could
be experienced as a form of utilitarian end-of-life
practice [7-10].
Recently, a regulatory framework making this type of
organ retrieval possible was debated in French parlia-
ment [11]. Up to our knowledge, there is no recent epi-
demiologic data describing French WoWt practices and
questioning whether those practices (patient concerned,
implemented measures) would be compatible with post-
mortem organ harvesting. On the basis of other coun-
tries experience, it is quite obvious that the period
between withdrawal of life-sustaining treatment and
death (so-called “the withdrawal period”) is a major de-
terminant of organ donation and of the quality of organsMaastricht classification [5] distinguishes four categories of circulatory
egory I) or with (category II) immediate cardiopulmonary resuscitation
foreseeable circulatory arrest occurring after a decision to withhold or
eft side of the panel), circulatory arrest occurring after brain death
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from a few minutes to many hours or days, depending
on the level of life support engaged at the time of WoWt
decision, and how withdrawal is achieved. As clinical
guidelines and rules in this area mainly focus on general
principles rather than practical details, there is no con-
sensus on the best airway management during the with-
drawal period (cessation/reduction of ventilation with/
without removal of the endotracheal tube). However, a
long withdrawal period often results in severe ischemic
damages compromising organ potential use for trans-
plantation [13].
We report the results of a single center retrospective
study designed 1) to describe the epidemiological char-
acteristics of patients deceased under a WoWt procedure
in a French ICU, 2) to run an a posteriori assessment of
their theoretical eligibility as organ donors by integrating
the measures surrounding WoWt decision and the poten-
tial impact of the withdrawal period on organ viability,
and 3) to confirm the feasibility of an ongoing French
multicenter survey (named “EPILAT”) given IRB approval
on 17 December 2012.
Methods
This pilot study on WoWt practices was carried out in a
16-bed medical-surgical ICU at Saint-Louis Hospital (La
Rochelle, France). The institutional review board (CPP
Paris Ile de France II, IRB registration: 00001072) ap-
proved the protocol (IRB approval n° 2012-11-08). The
study observation period ran from November 1, 2011 to
October 31, 2012. We retrospectively analyzed the me-
dical records of patients admitted to the ICU who un-
derwent a WoWt procedure in compliance with the
terms of the French Leonetti’s law governing end-of-life
care [14]. The determinants and procedural conditions
governing WoWt decisions follow the French Intensive
Care Society guidelines [15]. When current or further
life-sustaining treatments appear to be of no overall
benefit for a patient, physicians must respect a collegial
procedure before making any WoWt decision. The pro-
cedure takes into account the patient’s wishes spontan-
eously expressed or written in advance directives, the
opinion of the trusted person, as well as that of the fa-
mily and close relations. The procedure involves an in-
dependent corroboration of the diagnosis and prognosis.
In our unit, criteria for withholding or withdrawing
treatment are: advanced or terminal stage of a severe
and incurable disease, absence of curative strategy, ad-
equate period of time to confirm treatment failure, no
additional information needed for decision-making, very
high age, limited functional autonomy before hospital
admission, limited subsequent functional autonomy, li-
mited subsequent relational quality-of-life, patient’s wish
to limit treatment, perception of unreasonable obstinacyvoiced by patient’s loved ones [15]. WoWt measures im-
plemented may involve cardiopulmonary resuscitation,
ventilatory support, inotropic drugs, dialysis, antibiotics,
transfusion, urgent surgery, nutrition, and hydration.
Measures agreed on and arguments ensuing collegial de-
bates are recorded in the patient's chart. Patient’s next-
of-kin and staff are fully informed. If the patient is still
conscious and able to give assent, his agreement to the
WoWt features is thoroughly searched and confirmed.
The data recorded on confirmation of death included
age, gender, medical history, circumstances surrounding
admission, Simplified Acute Physiology Score (SAPS) II
index [16] on ICU admission, events occurring during
hospitalization, relevant clinical and biological charac-
teristics, Sequential Organ Failure Assessment (SOFA)
score [17] at the time of the WoWt decision, modalities
governing the WoWt decision (decision-making process,
subsequent measures), and outcome of the patient (death
or discharged alive). By convention, a SOFA organ sub-
score of three or more was considered a sign of organ
failure.
For patients who died under WoWt conditions, theo-
retical eligibility as organ donors was determined a
posteriori based on medical selection criteria, time from
withdrawal of life-sustaining treatment to death, and im-
pact of the WoWt measures on organ function. To con-
sider deceased patients as potential donors (regardless of
WoWt measures implemented), we excluded those with
general contraindications to organ donation (metastatic
or hematological malignancy, HIV infection, uncon-
trolled systemic sepsis, suspected prion disease), and
those with absolute organ-elective contraindications to
the use of kidney, liver, and lung for transplantation ac-
cording to the U.K. Guidelines for donation under
Maastricht III conditions [18]. Advanced age per se was
not considered a contraindication. Because hemodyna-
mic parameters during the withdrawal period were ir-
regularly available (due to the retrospective nature of
this study), an interval of 2 hours from treatment dis-
continuation to cessation of cardiac electrical activity
was considered the maximum time compatible with organ
viability [12,13].
Deidentified when collected, the data are compiled
into a spreadsheet and analyzed by the ward statistician.
The statistical analysis was descriptive. Continuous
variables are reported as means ± standard deviations.




During the study period, 596 patients (age: 67 ± 16 yr;
gender ratio M/F: 1.6; SAPS II: 54 ± 24) were admitted
to the ICU. Mean length of stay (LOS) was 10 days
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patients (63 ± 16 yr, SAPS II 47 ± 21) survived and were
discharged from the ICU after an average LOS of 9 days
(minimum 1 day–maximum 97 days). One hundred and
sixty-eight patients (28%) died in the ICU: 25 (15%) were
registered as brain death and 143 (85%) as circulatory
death. Over half the circulatory death patients (76/143,
i.e. 53%) underwent a formalized WoWt procedure and
subsequently died without resuscitation attempted given
the context (controlled CAD). For the 67 patients who
died of uncontrolled CAD, cardiac arrest could not be
reversed despite the resuscitation efforts made.Figure 2 Flowchart of the 596 patients with regards to the outcome a
withdraw treatment; ICU, intensive care unit; SAPS, Simplified Acute PhysioContext, determinants, and procedural conditions
governing the WoWt measures
Of the 596 patients admitted, 84 (14%; age: 71 ± 14 yr;
gender ratio M/F: 3.2; SAPS II: 69 ± 20) underwent
WoWt measures (Figure 2). The circumstances of admis-
sion of these patients, as described in the left-side panel of
Figure 3, were: acute respiratory distress for 27 patients,
out-hospital cardiac arrest successfully resuscitated for 26
patients, shock or multiple organ failure for 24 patients, 5
cases of stroke, 1 encephalitis, and 1 acute kidney failure.
On the day of the WoWt decision, organ failure(s)









Pathological settings of WoWtpatients
(n = 84)




Figure 3 Pathological settings of WoWt patients and eligible patients for organ harvesting. Of the 32 patients theoretically eligible as
potential donors, 18 had been admitted to the ICU after a successfully resuscitated cardiac arrest and were in persistent postanoxic coma when
the collegial WoWt decision was made. This condition counted for close to a third of WoWt patients (left chart) and more than half of the
patients theoretically eligible as organ donors before effective WoWt (right chart).
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renal (n = 24 patients), hematological (n = 12 patients),
and hepatic (n = 11 patients). On average, patients suffered
from 2 to 3 (2.3) organ failures.
Confirmed absence of curative strategy (n = 63 pa-
tients), limited subsequent functional autonomy (n = 74
patients), and limited subsequent relational quality of life
(n = 65 patients) were the rationales most often put for-
ward to justify WoWt decision.
For eight patients, life-sustaining cardiopulmonary sup-
port treatment was withdrawn. Withdrawal of life support
usually involved cessation of inotrope/vasoactive drugs
and/or discontinuation of ventilatory support. For the
other 76 WoWt patients, life-sustaining treatment was
limited by measures involving either withholding or pro-
gressively phasing out curative therapies. In all cases, com-
fort care, titrated sedation when needed, hydration, and
nutrition were continued.
WoWt patients’ outcome and theoretical eligibility for
organ donation
Of the 84 WoWt patients, 8 survived and were dis-
charged from the ICU, whereas 76 died of circulatory ar-
rest without attempted resuscitation (Figure 2). Mean
time from WoWt decision to death was 4.6 days (mini-
mum 0 day–maximum 36 days). Of the eight patients
for who life-sustaining cardiopulmonary support was
withdrawn, only three died less than 2 hours after treat-
ment withdrawal, four died more than 2 hours later, and
one survived and was discharged from the ICU. This co-
matose, postcardiac arrest patient died 3 days later in a
medical ward providing palliative care.
Of the 76 patients who died under WoWt, 20 already
presented a contraindication either before or on admissionto the ICU that ruled out any organ harvesting (16 meta-
static or hematologic malignancies, 3 cases of irrever-
sible multiple organ failure, 1 HIV infection). Twenty-four
more patients developed organ dysfunction during their
ICU stay (18 cases of multiple organ failure and 6 cases of
uncontrolled systemic sepsis). In 4 cases, onset of the
organ dysfunction occurred after WoWt measures had
been implemented. Therefore, 32 deceased patients (age:
70 ± 15 yr; gender ratio M/F: 2.3; SAPS II: 66 ± 15; SOFA
score: 7 ± 3) would ultimately have been eligible for dona-
tion of one or more organs based on medical graft selec-
tion criteria (regardless of WoWt measures implemented).
The original reason these potential donors were ad-
mitted to the ICU (Figure 3) was acute respiratory distress
(n = 10 patients), out-hospital cardiac arrest successfully
resuscitated (n = 18 patients), stroke (n = 3 patients), and
encephalitis (n = 1 patient). For 5 of those 32 eligible pa-
tients, life-sustaining cardiopulmonary support treatment
was withdrawn (without extubation). Only 3 of these 5 pa-
tients died less than 2 hours after treatment withdrawal,
the timeframe considered compatible with postmortem
organ retrieval (Table 1).
Discussion
Every day in ICUs, many patients whose organs could
potentially save the life of others die under WoWt con-
ditions. Because donation after CAD is still not, but
about to be legally framed in France [11], we designed
our study to obtain the largest overview of both WoWt
practices (not influenced by any other objective) and
patients concerned by such procedures. In this cohort
(84 WoWt patients), we a posteriori identified a subgroup
of 32 deceased patients theoretically eligible for organ
donation based on medical criteria for graft selection
Table 1 Characteristics of the 32 WoWt patients eligible to organ donation based on medical criteria for graft selection
Sex Age (yr) Clinical settings SAPS II SOFA Organ(s) theoretically eligible to donation
F** 76 Stroke 54 8 Kidney & liver
F** 90 End-stage respiratory disease 64 2 Kidney
M** 65 End-stage respiratory disease 27 14 Kidney
M 43 Post-resuscitation coma 61 4 Kidney
M 55 Post-resuscitation coma 65 7 Kidney & liver
F 73 Post-resuscitation coma 96 13 Liver
F 83 Post-resuscitation coma 62 7 Kidney
F 64 Post-resuscitation coma 68 7 Kidney
F 52 Post-resuscitation coma 61 8 Kidney, liver & lung
M 92 Post-resuscitation coma 62 8 Liver
M 73 Post-resuscitation coma 81 7 Liver
M 66 Post-resuscitation coma 59 12 Liver
M 56 Post-resuscitation coma 79 9 Liver
M 55 Post-resuscitation coma 79 7 Kidney
M 62 Post-resuscitation coma 78 10 Kidney & liver
M 82 Post-resuscitation coma 81 7 Kidney & liver
M 46 Post-resuscitation coma 71 7 Kidney & liver
M 54 Post-resuscitation coma 51 7 Kidney & liver
M 80 Post-resuscitation coma 56 8 Kidney & liver
M 79 Post-resuscitation coma 83 11 Kidney & liver
M 62 Post-resuscitation coma 50 5 Kidney & liver
F 93 End-stage respiratory disease 48 9 Liver
F 82 End-stage respiratory disease 70 3 Liver
M 84 End-stage respiratory disease 92 13 Liver
M 82 End-stage respiratory disease 82 5 Liver
M 78 End-stage respiratory disease 36 2 Kidney
M 88 End-stage respiratory disease 63 6 Kidney
M 89 End-stage respiratory disease 50 8 Kidney & liver
M 63 End-stage respiratory disease 84 4 Kidney & liver
F 80 Cerebrovascular accident 56 6 Kidney & liver
M 48 Cerebrovascular accident 69 11 Kidney
M 58 Encephalitis 67 3 Kidney & lung
The first five patients were withdrawn from life support (i.e., inotrope/vasoactive drugs and mechanical ventilation). The first three patients died within 120
minutes from life support withdrawal (**). All other patients underwent either withholding or progressive withdrawal of curative therapies. SAPS II, Simplified
Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment.
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many of these potential donors did not die within an
appropriately short time period after life-support with-
drawal [12,13], we concluded that our WoWt practices in
their current form (i.e., progressive removal of life-support
devices) would have been incompatible with further organ
harvesting.
Of the 32 patients theoretically eligible as potential
donors, 18 (56%) had been admitted to the ICU after a
successfully resuscitated cardiac arrest and were in persis-
tent postanoxic coma when the collegial WoWt decisionwas made (Figure 3). This condition counted for a third of
WoWt patients and more than half of the patients theo-
retically eligible as organ donors before effective WoWt.
Limitations of the study
The significance of these results remains limited to a
single-center, retrospective study conducted on a small
population (84 WoWt patients) and a short-lasting per-
iod (12 months). However, the epidemiological data col-
lected are comparable to those of previous multicenter
studies [19-21] in terms of proportion of ICU patients
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able circulatory arrest under WoWt settings (53%).
Our survey mixes up conscious and unconscious pa-
tients under WoWt conditions. In the United Kingdom,
where the rate of organ harvesting under Maastricht III
conditions is one of the highest in the world, the most
common diagnoses in donors are severe and irreversible
brain injuries [22]. However, conscious patients suffering
from irreversible severe diseases with no hope for im-
provement (for example end-stage respiratory disease,
locked-in syndrome, atrophic lateral sclerosis) may re-
quest both life-support withdrawal (i.e., turn off mechan-
ical ventilation) and subsequent organ donation if not
contraindicated [22-24]. In France, Leonetti’s law applies
to conscious or unconscious patients, in end-of-life situ-
ation or with irreversible and severely-disabling diseases
[14]. As donation under Maastricht III conditions is still
not legally framed, we deliberately considered every
possible scenario encountered in other public health
systems.
It is not the duration per se but the hemodynamic pro-
file during the withdrawal period that determines the
consequences of warm ischemia on organ viability [12].
However, because of the retrospective nature of this
study (not influenced by any ulterior motive), hemody-
namic parameters during the withdrawal period were
rarely available. Moreover, troublesome monitoring often
was switched off to leave the patient and relatives peace-
ful. We arbitrarily considered that an interval of 2 hours
from treatment withdrawal to cessation of cardiac elec-
trical activity was the maximum withdrawal period com-
patible with an hypothetical organ harvesting [12,13].
As organ donation under Maastricht III settings is still
not legally framed in France, this study does not address
the question of patient/family consent. We keep in mind
that the rate of refusal would significantly impact the
amount of potential donors proceeding to donation.
Conditions governing withdrawal of life-sustaining
support and time to cardiac death
The WoWt procedures formalized in this study were al-
ways established through a systematic, daily collective
discussion designed to determine the most appropriate
level of care for each hospitalized patient. End-of-life
care in France is legally framed under the French law
2005–370 of April 22, 2005 relating to Patients’ rights
and to the end of life (so called Leonetti’s law), which
authorizes the withholding or withdrawal of curative
therapies when deemed “useless, disproportionate or to
have no other effect than solely the artificial preservation
of life” [14]. Continuing such treatment with no hope of
cure or benefit would equate to an unreasonable obsti-
nacy, especially for patients who are no longer able to
express their wishes. In this setting, the law stipulatesthat any WoWt decision may only be taken after a
formal procedure of collegial debates. Obtaining an ex-
ternal opinion from an independent consultant is a com-
pulsory part of the procedure. In addition to medical
factors, the Leonetti’s law stipulates that the discussions
must integrate the patient’s wishes voiced or written in
advance directives, the opinion of the trusted person (if
appointed), as well as that of the family and close rela-
tions. All proceedings and decisions taken during discus-
sions are recorded in the patient’s medical file. Despite
the collegial nature of the procedure, the physician in
charge of the patient remains liable for the final decision.
Once a life-support withdrawal decision has been made,
delivering comfort care becomes priority. While the tech-
nical environment of our ICU does not offer optimal
conditions for a quiet end-of-life, therapies from this
point exclusively focus on relieving pain, anxiety, and
discomfort—what needs to be done when there is nothing
more to be done.
Because circulatory arrest must occur after a short
period, only the withdrawal of life-sustaining cardiopul-
monary support for highly-dependent patients (high in-
spired oxygen fraction (FiO2), nontriggered modes of
ventilation, inotrope/vasoactive drug use) is compatible
with postmortem organ donation [12,13,25-27]. In our
study, cardiopulmonary support was withdrawn in 8 of
the 84 WoWt patients, 3 of whom died within the first
120 minutes of withdrawal (the maximum delay compa-
tible with organ viability and graft quality for potential
donor grafts). We registered a single episode of extu-
bation in 1 of the 84 patients who finally presented no
clinical sign of obstruction. This postanoxic comatose
patient was given scopolamine and methylprednisolone
prior to extubation. Discharged from the ICU, he died 3
days later in a medical ward providing palliative care.
Seven additional WoWt patients discharged from the
ICU finally left the hospital alive, thus confirming the
intention of WoWt measures, which is to let nature take
its course (given the irreducible uncertainty about prog-
nosis for critically ill patient) without searching to has-
ten death. Indeed, there is significant variation in how
treatment withdrawals are implemented in ICUs, par-
ticularly with regards to airway management. Published
guidelines mainly focus on the decision-making princi-
ples rather than practical details about how end-of-life
care should be managed. Once artificial breathing sup-
port is switched off, it becomes possible to remove the
endotracheal tube that connects the patient to the venti-
lator and secures the airway [10]. Rather than an abrupt
“on-off” discontinuation of mechanical ventilation, with
or without extubation, many teams prefer a progressive
withdrawal of mechanical ventilation (termed “terminal
weaning”), because they feel the physical symptoms of air-
way obstruction may harm the patient and be distressing
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this progressive weaning as an unnecessarily prolonged
agony if death is the only possible outcome [29].
Ethical dilemma between the responsibility to deliver the
best care to the dying patient and the need to harvest his
organs
This study was led under conditions enabling a state-of-
play of ongoing practices without the physicians respon-
sible for WoWt decisions being pressured by any moral
dilemma between the individual interest of the dying pa-
tient and the collective benefit for potential graft reci-
pients. Although not expressly forbidden under current
French law, organ harvesting after controlled circulatory
death is still not practiced “so as to rule out any potential
tension between the decision to withdraw treatment and
the intention to harvest organs” [7]. In other countries,
teams involved in organ retrieval after controlled death
consider organ donation as a routine part of end-of-life
care once it is established that the patient wishes to be a
donor [10,22,30,31]. Of the 32 patients theoretically eli-
gible as organ donors before effective WoWt measures in
our study, 22 presented severe brain lesions and were de
facto, unable to express their wishes. Because organ dona-
tion under Maastricht III conditions is still not practiced
in France, patient’s relatives were never asked to provide
their loved one’s position on this particular question.
Moreover, the medical records before ICU admission
made no mention of anticipated directives or of a le-
gally designated trusted person.
Enrolling death into an organ harvesting procedure
would entail a number of organizational constraints that
may interfere with the comfort care given to the dying
patient and their loved ones. In countries that already
authorize organ donation after CAD, in order to meet
the time framework tied to organ viability, life-support is
withdrawn either in the operating room or in the ICU
provided that the patient can be swiftly transferred to
the operating room once death certified [22]. These oper-
ational requirements contrast with the regular palliative
approach (i.e., with no intention of organ harvesting).
Even though it is theoretically possible to maintain contact
between the patient and relatives up to surgical interven-
tion, the technical environment of an operating room is
far from the ideal place to organize spiritual assistance
and end-of-life rituals [32]. Furthermore, the quality of the
organs harvested under such conditions is closely depen-
dent on how early technical organ preservation measures
are implemented. One of these technical measures con-
sists in catheterizing the aorta and inferior vena cava in
order to connect an extracorporeal pump and maintain
circulation in the abdominal organs. Once futile treat-
ments get discontinued according to a formal collegial
debate, any intrusive intervention practiced before thesubject is declared dead could be seen as conflicting
with efforts to deliver terminal comfort care. Moreover,
such a procedure could even become intolerable for rela-
tives and care staff if the eventuality of a prolonged agonal
period making organ retrieval impossible has not been ex-
plicitly addressed beforehand. It is thus essential to pre-
cisely predict time to cardiac death after withdrawal of
life-sustaining treatment [13,25,27]. Any patient for which
the elective WoWt measure is not withdrawal of life-
sustaining treatment therefore should be definitively ex-
cluded from any intention to retrieve organs.
Conclusion
In this single-center study, a significant number of pa-
tients who died under WoWt procedures would have
theoretically been eligible for organ harvesting based on
routine medical criteria for graft selection. However,
WoWt measures implemented in our ICU are incompa-
tible with this type of organ retrieval, as the prolonged
agonal period would irreversibly compromise organ qua-
lity and graft viability. A multicenter study performed
under the same conditions has been launched in the first
half of 2013 to characterize WoWt practices in France
and to evaluate the organ donor eligibility of patients
dying under such conditions. It thus seems crucial to
focus on the factors determining how and when life sup-
port has to be withdrawn, particularly discontinuing me-
chanical ventilation and removing the endotracheal tube.
Finally, a sensitive issue may arise in a near future: in
which context are we medically and ethically entitled to
revise our practices and make them suitable for donation
after controlled circulatory arrest death?
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